Compositions containing moxifloxacin for treating otic infections

US8993636B2 · kind B2 · utility

Assignee

• Alcon Pharmaceuticals, Ltd. · CH

Inventors

• Gerald D. Cagle · Fort Worth, US
• Robert L. Abshire · Fort Worth, US
• David W. Stroman · Portage, US
• John M. Yanni · Burleson, US

Key dates

• Filing date: Oct 25, 2013
• Grant date: Mar 31, 2015
• Expiry date: Oct 25, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P27/16
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.